医学
梗阻性心肌病
结直肠癌
外科
麻醉
癌症
肥厚性心肌病
内科学
作者
Yongchang Shi,Chengchao Zuo,Yiwen Zhang,Chao Zhou,Fengjiao Zhang,Xiuhua Zhao
出处
期刊:Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2024-03-01
卷期号:103 (9): e37199-e37199
标识
DOI:10.1097/md.0000000000037199
摘要
Background: The goal of anesthesia in patients with hypertrophic obstructive cardiomyopathy (HOCM) is to reduce the risk of left ventricular outflow tract obstruction triggered by anesthetics. Remimazolam is a newly developed anesthetic that has been reported to have superior hemodynamic stability. There have been no reports on the completion of non-cardiac surgery with remimazolam in patients with HOCM. Methods: Here we report the case of a 49-year-old man diagnosed with hypertrophic obstructive cardiomyopathy who underwent resection of colon cancer with remimazolam and remifentanil anesthesia. A bolus 0.3 mg/kg remimazolam was administered for anesthesia induction, and then adjusted to 2 mg/kg/h to maintain anesthesia. Set the pain threshold index to 50 to auto-control the infusion speed of remifentanil. Results: No hypotension occurred during anesthesia, and norepinephrine was not administered. After conversion to open surgery, the patient’s blood pressure elevated and reduced with urapidil and esmolol. Conclusion: In this patient with HOCM, remimazolam and remifentanil provided adequate anesthesia for induction and maintenance to complete the right hemicolectomy.
科研通智能强力驱动
Strongly Powered by AbleSci AI